Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | | 196.9K | $3.47M | - |
| Other | | 195.8K | $3.45M | - |
| VP | | 122.3K | $2.16M | - |
| Other | | 94.7K | $1.67M | - |
| Other | | 87.5K | $1.54M | - |
| ? | | 70.0K | $1.23M | - |
| CFO | | 66.1K | $1.17M | - |
| ? | Karnani Vikram | 59.7K | $1.05M | - |
| ? | | 35.0K | $617.2K | - |
| ? | | 35.0K | $617.2K | - |
| ? | | 35.0K | $617.2K | - |
| ? | | 35.0K | $617.2K | - |
| ? | | 35.0K | $617.2K | - |
| ? | | 35.0K | $617.2K | - |
Transactions
50 transactions · page 7
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2023-06-15 | Scalzo Richard William | See Remarks | Sale+OE | 51,390 | $12.71 | $653,177.70 | -25.5% | → |
| 2023-06-13 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 1,625 | $12.43 | $20,198.75 | -1.5% | → |
| 2023-06-13 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 1,475 | $12.43 | $18,334.25 | -1.7% | → |
| 2023-06-13 | Farwell Wildon | Chief Medical Officer | Sell | 1,698 | $12.43 | $21,106.14 | -1.8% | → |
| 2023-06-13 | McNeill Jonathan | See Remarks | Sell | 2,259 | $12.68 | $28,649.37 | -1.7% | → |
| 2023-06-12 | Brumm Joshua T | See Remarks | Sale+OE | 325,330 | $12.90 | $4,195,796.64 | -23.2% | → |
| 2023-03-14 | Brumm Joshua T | See Remarks | Sell | 7,318 | $13.33 | $97,548.94 | -2.2% | → |
| 2023-03-14 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 1,416 | $13.33 | $18,875.28 | -1.6% | → |
| 2023-03-14 | Scalzo Richard William | See Remarks | Sell | 1,311 | $13.33 | $17,475.63 | -2.3% | → |
| 2023-03-14 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 1,559 | $13.33 | $20,781.47 | -1.4% | → |
| 2023-03-14 | Farwell Wildon | Chief Medical Officer | Sell | 7,441 | $13.33 | $99,188.53 | -7.4% | → |
| 2023-03-14 | McNeill Jonathan | See Remarks | Sell | 2,209 | $13.18 | $29,115.97 | -1.6% | → |
| 2023-01-18 | McNeill Jonathan | See Remarks | Sale+OE | 10,000 | $14.03 | $140,300.00 | -12.9% | → |
| 2023-01-09 | McNeill Jonathan | See Remarks | Sell | 30,150 | $11.57 | $348,835.50 | -30.8% | → |
| 2022-12-12 | Rhodes Jason P | Director | Buy | 934,581 | $10.70 | $10,000,016.70 | New | → |
| 2022-12-12 | Atlas Venture Opportunity Fund II, L.P. | 10% Owner | Buy | 934,581 | $10.70 | $10,000,016.70 | New | → |
| 2022-12-12 | Scalzo Richard William | See Remarks | Sell | 312 | $10.87 | $3,391.44 | -0.6% | → |
| 2022-12-12 | McNeill Jonathan | See Remarks | Sell | 472 | $10.87 | $5,130.64 | -0.5% | → |
| 2022-12-12 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 751 | $10.87 | $8,163.37 | -0.7% | → |
| 2022-12-12 | Brumm Joshua T | See Remarks | Sell | 3,322 | $10.87 | $36,110.14 | -1.0% | → |
| 2022-12-12 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 680 | $10.87 | $7,391.60 | -0.7% | → |
| 2022-12-12 | Farwell Wildon | Chief Medical Officer | Sell | 628 | $10.87 | $6,826.36 | -0.6% | → |
| 2022-10-10 | Brumm Joshua T | See Remarks | Sale+OE | 210,000 | $12.52 | $2,629,522.00 | -33.9% | → |
| 2022-03-11 | Scalzo Richard William | See Remarks | Sell | 308 | $8.73 | $2,688.84 | -1.1% | → |
| 2022-03-11 | McNeill Jonathan | See Remarks | Sell | 481 | $8.73 | $4,199.13 | -0.8% | → |
| 2022-03-11 | Farwell Wildon | Chief Medical Officer | Sell | 640 | $8.73 | $5,587.20 | -1.0% | → |
| 2022-03-11 | Brumm Joshua T | See Remarks | Sell | 3,384 | $8.73 | $29,542.32 | -1.6% | → |
| 2022-03-11 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 693 | $8.73 | $6,049.89 | -1.3% | → |
| 2022-03-11 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 765 | $8.73 | $6,678.45 | -1.0% | → |
| 2022-03-02 | Farwell Wildon | Chief Medical Officer | Sell | 5,617 | $8.56 | $48,081.52 | -7.8% | → |
| 2021-09-23 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 2,451 | $17.22 | $42,206.22 | -6.8% | → |
| 2021-09-21 | McNeill Jonathan | See Remarks | Sell | 1,274 | $15.90 | $20,251.64 | -1.7% | → |
| 2021-09-21 | Brumm Joshua T | See Remarks | Sell | 8,009 | $15.90 | $127,312.49 | -3.8% | → |
| 2021-09-21 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 1,444 | $15.90 | $22,954.34 | -3.8% | → |
| 2021-09-21 | Scalzo Richard William | See Remarks | Sell | 859 | $15.90 | $13,654.99 | -3.8% | → |
| 2020-09-21 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | 660,000 | $19.00 | $12,540,000.00 | +30.8% | → |
| 2020-09-21 | Logos Global Management LP | 10% Owner | Buy | 700,000 | $19.00 | $13,300,000.00 | +87.0% | → |
| 2020-09-21 | VV Manager II, LLC | 10% Owner | Buy | 792,995 | $19.00 | $15,066,905.00 | +38.0% | → |